Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(22%)

Phase Distribution

Ph not_applicable
8
89%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
N/ANon-phased studies
8(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(2)
Terminated(2)
Other(5)

Detailed Status

unknown5
Completed2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A8 (100.0%)

Trials by Status

completed222%
unknown556%
terminated222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9